Stretch Marks Fading: Labs, Causes, and Next Steps

Why stretch marks fade

Stretch marks, or striae distensae, are linear dermal scars. Early lesions are called striae rubrae. They may look red, pink, purple, brown, or darker than surrounding skin depending on skin tone. Mature lesions are called striae alba and are often paler, slightly depressed, and less vascular.

The color transition is part of scar maturation. Early lesions have more vascular and inflammatory activity. Over time, blood vessels become less conspicuous and collagen and elastic-fiber organization changes. Reviews of striae biology describe flattened epidermis, altered collagen bundles, and reduced or fragmented elastic fibers in mature lesions [1,2].

There is no exact universal timetable. Color can change over months or longer, and texture may remain after color fades. Pregnancy, puberty, location, baseline skin color, genetics, corticosteroid exposure, and ongoing body-size change can affect appearance. A statement that every stretch mark turns white by a fixed month is more precise than the evidence supports.

Common causes and settings

Striae often develop when skin growth and dermal remodeling are out of balance. Common settings include:

• pregnancy;
• adolescent growth and puberty;
• rapid weight gain or loss;
• rapid muscle gain;
• obesity or substantial changes in body composition;
• prolonged or high-potency topical corticosteroid use;
• systemic, injected, or inhaled glucocorticoid exposure;
• endogenous cortisol excess, which is much less common than physiologic striae.

Pregnancy-related risk is influenced by age, family history, skin properties, body-size change, and pregnancy factors. A review of striae gravidarum found that prediction and prevention remain imperfect [12]. Developing striae does not mean weight gain was excessive or that a person failed to use the right cream.

Weight loss does not usually make the scar biologically worse. Less subcutaneous volume or greater skin laxity can make an existing mark look more visible. There is no reliable evidence that a particular GLP-1 medicine uniquely causes stretch marks independent of the body-size change around treatment.

When fading is reassuring

Fading is generally reassuring when marks appeared during pregnancy, puberty, growth, weight change, or muscle gain and no other concerning symptoms are developing. Typical marks can be diagnosed visually. Blood tests, biopsy, DHEA-S, thyroid testing, growth hormone, and IGF-1 are not routine tests for otherwise typical striae.

A clinician may still examine a new rash because several conditions can be mistaken for stretch marks. Linear morphea, steroid skin atrophy, scarring, infection, and other dermatoses can have different texture, symptoms, or distribution.

Features that justify medical evaluation

Striae associated with Cushing syndrome are classically broad and violaceous, but appearance alone is not enough to diagnose cortisol excess. The Endocrine Society guideline recommends testing people with multiple and progressive features, especially features with greater discriminatory value, after first excluding exogenous glucocorticoid exposure [4].

Features that increase concern include:

• new broad purple or violaceous striae without a clear mechanical trigger;
• easy bruising with little trauma;
• facial plethora;
• progressive proximal muscle weakness, such as difficulty rising from a chair;
• unexplained osteoporosis or fractures at a young age;
• new difficult-to-control hypertension or diabetes alongside other Cushing features;
• growth slowing with weight gain in a child;
• an adrenal mass plus a compatible clinical pattern.

Many common symptoms, including fatigue, weight gain, acne, depression, and irregular periods, are nonspecific. Testing every person with one common feature can produce false positives. A 2022 analysis revisiting guideline-based screening found that multiple symptoms and features such as myopathy or an adrenal incidentaloma were more informative than broad population screening [5].

Review every form of corticosteroid exposure

Before endocrine testing, review oral steroids, injections, inhalers, nasal sprays, high-potency creams, skin-lightening products, and supplements that may contain undeclared glucocorticoids. Potent topical steroids used under occlusion or for long periods can thin skin and cause local striae. The right response may be medication review and a safer treatment plan, not a cortisol workup.

If Cushing syndrome is suspected

The recommended initial tests include one of the following approaches, selected for the individual clinical setting: repeated late-night salivary cortisol, repeated 24-hour urinary free cortisol, an overnight 1-mg dexamethasone suppression test, or a longer low-dose dexamethasone suppression test [4]. Random serum cortisol and ACTH are not recommended as screening tests.

One abnormal result does not by itself establish Cushing syndrome. Sleep schedule, shift work, alcohol, depression, acute illness, medication interactions, estrogen use, kidney function, urine collection quality, and assay method can affect interpretation. The Endocrine Society diagnostic pathway recommends a second appropriate test and endocrinology evaluation after an abnormal initial result [4].

DHEA-S, thyroid tests, glucose testing, or other laboratory studies may be ordered for a separate clinical question, but they are not a standard “stretch-mark panel.” Marfan syndrome is diagnosed from cardiovascular, ocular, skeletal, family-history, and genetic criteria, not from GH or IGF-1 testing because striae are present.

A practical next-step pathway

1. Identify the stage. Early striae have more color; mature striae are paler and more scar-like. Treatment evidence and targets differ.

2. Reconstruct the trigger. Note pregnancy, puberty, body-size or muscle change, corticosteroid use, timing, and whether new lesions are still appearing.

3. Look for a syndrome, not one isolated sign. Broad violaceous striae plus progressive weakness, bruising, facial plethora, hypertension, diabetes, osteoporosis, or slowed childhood growth deserve medical evaluation.

4. Decide whether the goal is reassurance or cosmetic improvement. Typical fading needs no medical treatment. Procedures are elective and should have realistic expectations.

5. Match treatment to skin type and striae stage. Discuss pigment-change risk, downtime, pregnancy status, medications, cost, and the experience of the treating dermatologist.

6. Photograph consistently. The same lighting, distance, angle, and skin tension make change easier to judge than memory or marketing photographs.

Treatment: what the evidence supports

No treatment consistently removes stretch marks. Trials are often small, use different scoring systems, combine early and mature striae, and have limited long-term follow-up. A systematic review of therapeutic targets concluded that better randomized trials are needed before firm comparative recommendations can be made [3].

Topical tretinoin

An older randomized trial found that daily topical tretinoin improved early, active stretch marks compared with vehicle over six months [6]. The evidence applies mainly to early striae, not long-standing white marks. Irritation, peeling, and pigment change can occur.

Topical retinoids are generally avoided during pregnancy. Anyone pregnant, trying to conceive, or breastfeeding should review treatment with the relevant clinician rather than relying on an old pregnancy-letter category. Over-the-counter retinol is not proven to erase striae and is not equivalent to the studied prescription regimen.

Microneedling and microneedle radiofrequency

Microneedling creates controlled dermal injury intended to stimulate remodeling. A 2024 systematic review and meta-analysis found preliminary evidence of improvement, while also showing variation between studies and treatment types [7]. Pain, infection, scarring, and post-inflammatory hyperpigmentation are possible. Home rollers do not reproduce a controlled clinical procedure and can add contamination or injury risk.

Microneedle radiofrequency adds energy delivery at depth. Comparative evidence is growing, but device settings, operator technique, and patient selection vary. Darker skin types require careful planning to reduce pigment complications.

Fractional lasers

Ablative fractional carbon-dioxide laser and other fractional devices can improve texture in some mature striae. A 2025 meta-analysis of six randomized trials found broadly similar clinical improvement between fractional CO2 laser and microneedling approaches, with more post-inflammatory hyperpigmentation in the CO2 groups [8]. That tradeoff is important when selecting treatment for darker skin.

Nonablative fractional lasers, vascular lasers, and other energy devices may be selected based on color and texture. Early red striae and mature pale striae do not have the same target. There is no defensible basis for naming one device “best” for every patient.

Radiofrequency, platelet-rich plasma, and combinations

A network meta-analysis compared multiple topical and procedural approaches but was limited by small trials and an indirect evidence network [9]. Combination treatments may rank well in an analysis without proving superiority in a large, high-quality head-to-head trial. Platelet-rich plasma, microdermabrasion, carboxytherapy, and intense pulsed light remain options with variable evidence rather than standard cures.

Moisturizers

Moisturizer can improve dryness, itch, and comfort. It does not reconstruct fragmented elastic fibers or reliably erase a mature scar. This distinction helps prevent expensive products from being sold as proven tissue repair.

Prevention during pregnancy

Prevention trials have not established a topical product that reliably prevents pregnancy stretch marks. A Cochrane review found no high-quality evidence supporting commonly used topical preparations [10]. ACOG similarly states that marketed products have not been proven to prevent or remove striae, although moisturizer may help itching and softness [11].

Normal pregnancy weight guidance supports overall maternal and fetal health but cannot guarantee prevention. Genetics and skin response remain important. Products advertised with before-and-after images should not be confused with randomized evidence.

Choosing a dermatologist or procedure

A useful consultation should identify whether the marks are rubrae or alba, discuss how the device performs in the patient’s skin type, show unretouched results in comparable skin, and describe expected sessions, downtime, pain control, pigment risk, and what counts as a meaningful response.

Be cautious with claims of permanent removal, guaranteed percentage improvement, or a package sold before diagnosis. Improvement is usually partial. A procedure that changes texture may not fully change color, and vice versa.

When to seek quicker assessment

Prompt evaluation is appropriate for rapidly appearing broad violaceous striae with progressive weakness or easy bruising, a child with weight gain and slowed height growth, skin breakdown or infection in steroid-treated areas, or new concerning symptoms after long-term glucocorticoid exposure. Typical fading without these features is not an emergency.